Note: The job is a remote job and is open to candidates in USA. Meitheal Pharmaceuticals is an emerging biopharmaceutical company developing and commercializing biosimilars, insulin products, specialty biologics, and branded therapeutics for the U.S. market. The Senior Director, National Accounts will lead market access strategy and payer/PBM relationships, negotiate contracts, and build the operations and partnerships needed to scale access across the company’s portfolio.

Responsibilities

• Develop and execute account-specific strategies to secure optimal access for Meitheal’s marketed biosimilars, insulin products, specialty biologics, and branded therapeutics across both the medical benefit and pharmacy benefit
• Lead access planning for pipeline products, engaging accounts early in the product lifecycle to shape coverage architecture, contracting terms, and reimbursement pathways ahead of launch
• Navigate the full spectrum of access mechanisms: formulary placement (including commercial, Part D formulary positioning for insulin and pharmacy-dispensed products), medical policy coverage, buy & bill economics, specialty pharmacy distribution, prior authorization and step therapy protocols, and contract-based preferred positioning
• Develop and execute payer strategies specific to the insulin/diabetes franchise, including Part D Senior Savings Model dynamics, IRA implications, and competitive positioning against established insulin manufacturers
• Negotiate and execute contracts that balance access breadth with margin protection across the portfolio
• Own the commercial terms (rebates, discounts, performance-based agreements, and administrative fees) for assigned accounts
• Develop contracting strategies for pipeline assets, including biologics and specialty products beyond the current biosimilar and insulin portfolio
• Manage gross-to-net implications and protect pricing integrity (including ASP for physician-administered products and WAC/net pricing for pharmacy-dispensed insulins)
• Play a foundational role in building Meitheal’s market access operations, contributing to the development of processes, tools, analytics capabilities, contracting infrastructure, and account management frameworks
• Partner with leadership to define the long-term market access organizational structure as the specialty portfolio scales
• Identify capability gaps and recommend investments in systems, data, and talent to support growth
• Serve as an internal subject matter expert on payer/account dynamics, reimbursement policy, and competitive access intelligence
• Partner with Commercial, Medical Affairs, Legal, Finance, Regulatory, and Trade/Distribution to align account strategy with corporate objectives
• Provide market access input into pricing decisions, launch sequencing, and portfolio prioritization
• Deliver competitive intelligence on account-level dynamics (formulary changes, contract shifts, policy updates, and emerging access barriers) that inform enterprise-level decision-making
• Serve as a senior Meitheal representative in all account interactions, maintaining executive-level relationships with key decision-makers
• Represent Meitheal at relevant industry forums and conferences
• Provide strategic counsel to Meitheal leadership on the evolving access landscape and its implications for commercial strategy

Skills

• Demonstrated, current executive-level relationships with key decision-makers across multiple customer segments; this is the most critical qualification for success in the role
• Proven track record of negotiating contracts that resulted in measurable access gains and revenue impact
• Direct experience with biologic, biosimilar, insulin and/or branded therapeutic products
• Experience operating in emerging or high-growth company environments where building infrastructure is as important as executing against it
• Comfort with ambiguity, resourcefulness, and the ability to operate without a large support structure
• Bachelor's degree required
• 15+ years of progressive experience in pharmaceutical/biotechnology market access or national account management
• Microsoft Word, Excel and PowerPoint
• Microsoft Outlook and Teams
• Experience with insulin market access, including Part D formulary dynamics, the $35 cap environment, and competitive positioning
• Experience launching products into competitive multi-source biologic, biosimilar, and branded therapeutic markets
• Understanding of both medical benefit (Part B / buy & bill) and pharmacy benefit (Part D / PBM-managed) access dynamics
• Experience with specialty product access, including limited distribution, specialty pharmacy networks, and hub/patient services integration
• Familiarity with 340B program dynamics and their contracting implications
• Understanding of IRA/Inflation Reduction Act implications for manufacturer contracting obligations (Medicare Redesign, manufacturer discount program, negotiated pricing)
• Prior experience at a company that scaled its commercial infrastructure (vs. inheriting a mature organization)
• MBA, PharmD, or advanced degree preferred

Benefits

• Target bonus
• Medical, dental, and vision insurance
• Flexible spending accounts
• Long- and short-term disability insurance
• Life insurance
• 401(k) plan with employer contribution
• Competitive PTO
• Company-paid holidays
• Paid parental leave (maternity & paternity)
• Car Allowance
• Remote working

Company Overview